Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, March 05, 2026 (GLOBE NEWSWIRE) -- The "GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report by Product (Trulicity, Wegovy, Ozempic, Mounjaro), Application (Diabetes,...
-
Dublin, March 04, 2026 (GLOBE NEWSWIRE) -- The "GLP-1 Receptor Agonist - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for GLP-1...
-
Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "GLP-1 Receptor Agonist Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The GLP-1 receptor agonist...
-
Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Japan Auto-Injectors for Glp-1 Receptor Agonists Market Outlook 2038" report has been added to ResearchAndMarkets.com's offering.Japan auto-injectors...
-
Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The peptide API market has shown promising growth in recent years, reaching a valuation of US$ 9.2...
-
Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness...
-
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Global GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report by Product (Trulicity, Wegovy, Ozempic, Mounjaro), Application (Type 2...
-
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "GLP-1 Receptor Agonist Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global market for GLP-1 receptor...
-
SAN FRANCISCO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- ProLynx and Daiichi Sankyo Company, Limited, announced today the publication of a paper in the journal TVST entitled “A controlled release system for...
-
SAN FRANCISCO, April 03, 2018 (GLOBE NEWSWIRE) -- ProLynx announced today the publication of a paper demonstrating its leading capabilities to exploit primary deuterium kinetic isotope effects...